Posts by Tags

BPG

Best Practice Guide for Biomolecular QM/MM simulations with CP2K

1 minute read

Published:

As part of my work in the BioExcel-2 project at the EPCC, I co-wrote a best practice guide on how to perform QM/MM simulations of biomolecules using CP2K. We provided an overview of the main steps in setting up and running a QM/MM simulation in CP2K. We cover steps starting from preparing your system to running a production QM/MM run. This BPG is designed to be read from the point of view of beginner users.

CP2K

Best Practice Guide for Biomolecular QM/MM simulations with CP2K

1 minute read

Published:

As part of my work in the BioExcel-2 project at the EPCC, I co-wrote a best practice guide on how to perform QM/MM simulations of biomolecules using CP2K. We provided an overview of the main steps in setting up and running a QM/MM simulation in CP2K. We cover steps starting from preparing your system to running a production QM/MM run. This BPG is designed to be read from the point of view of beginner users.

IDR

My postdoctoral work is finally published in Chemical Science.

less than 1 minute read

Published:

My postdoctoral work on the selectivity of a drug-like small molecules on the oncoprotein MDM2 is finally out in Chemical Science. While I was a PDRA at the group of Dr Julien Michel at the University of Edinburgh, we explored the molecular determinants that guide the binding of Nutlin-3a and AMG-7209 to MDM2, which involves the disorder-to-order transition of the intrinsically disordered N-terminal region of MDM2. Moreover, we developed a protocol able to accurately estimate the binding affinities of these ligands using complete thermodynamic analysis that featured adaptive absolute alchemical free energy of binding calculations with enhanced-sampling molecular dynamics simulations.

MDM2

My postdoctoral work is finally published in Chemical Science.

less than 1 minute read

Published:

My postdoctoral work on the selectivity of a drug-like small molecules on the oncoprotein MDM2 is finally out in Chemical Science. While I was a PDRA at the group of Dr Julien Michel at the University of Edinburgh, we explored the molecular determinants that guide the binding of Nutlin-3a and AMG-7209 to MDM2, which involves the disorder-to-order transition of the intrinsically disordered N-terminal region of MDM2. Moreover, we developed a protocol able to accurately estimate the binding affinities of these ligands using complete thermodynamic analysis that featured adaptive absolute alchemical free energy of binding calculations with enhanced-sampling molecular dynamics simulations.

Outreach

Summer school

amr

drug design

My postdoctoral work is finally published in Chemical Science.

less than 1 minute read

Published:

My postdoctoral work on the selectivity of a drug-like small molecules on the oncoprotein MDM2 is finally out in Chemical Science. While I was a PDRA at the group of Dr Julien Michel at the University of Edinburgh, we explored the molecular determinants that guide the binding of Nutlin-3a and AMG-7209 to MDM2, which involves the disorder-to-order transition of the intrinsically disordered N-terminal region of MDM2. Moreover, we developed a protocol able to accurately estimate the binding affinities of these ligands using complete thermodynamic analysis that featured adaptive absolute alchemical free energy of binding calculations with enhanced-sampling molecular dynamics simulations.

prace

qmmm

Best Practice Guide for Biomolecular QM/MM simulations with CP2K

1 minute read

Published:

As part of my work in the BioExcel-2 project at the EPCC, I co-wrote a best practice guide on how to perform QM/MM simulations of biomolecules using CP2K. We provided an overview of the main steps in setting up and running a QM/MM simulation in CP2K. We cover steps starting from preparing your system to running a production QM/MM run. This BPG is designed to be read from the point of view of beginner users.

resources

snellius